These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 19534300)

  • 1. Evidence-based medicine and electrophysiology in schizophrenia.
    Galderisi S; Mucci A; Volpe U; Boutros N
    Clin EEG Neurosci; 2009 Apr; 40(2):62-77. PubMed ID: 19534300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder.
    Johannesen JK; O'Donnell BF; Shekhar A; McGrew JH; Hetrick WP
    Schizophr Bull; 2013 Nov; 39(6):1219-29. PubMed ID: 22927673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review.
    Perrottelli A; Giordano GM; Brando F; Giuliani L; Mucci A
    Front Psychiatry; 2021; 12():653642. PubMed ID: 34017273
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?
    Molina V; Lubeiro A; de Luis Garcia R; Gomez-Pilar J; Martín-Santiago O; Iglesias-Tejedor M; Holgado-Madera P; Segarra-Echeverría R; Recio-Barbero M; Núñez P; Haidar MK; Fernández-Sevillano J; Sanz-Fuentenebro J
    J Psychiatry Neurosci; 2020 Sep; 45(5):322-333. PubMed ID: 32100521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis.
    Wada M; Kurose S; Miyazaki T; Nakajima S; Masuda F; Mimura Y; Nishida H; Ogyu K; Tsugawa S; Mashima Y; Plitman E; Chakravarty MM; Mimura M; Noda Y
    J Affect Disord; 2019 Sep; 256():234-249. PubMed ID: 31200163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms in schizophrenia.
    Boutros NN; Mucci A; Diwadkar V; Tandon R
    Clin Schizophr Relat Psychoses; 2014 Apr; 8(1):28-35B. PubMed ID: 23428787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG correlates of the severity of posttraumatic stress symptoms: A systematic review of the dimensional PTSD literature.
    Lobo I; Portugal LC; Figueira I; Volchan E; David I; Garcia Pereira M; de Oliveira L
    J Affect Disord; 2015 Sep; 183():210-20. PubMed ID: 26025367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive ERP recording increases the amplitude of the endogenous P300 peak in schizophrenia.
    Price GW
    Schizophr Res; 2000 Feb; 41(3):463-72. PubMed ID: 10728723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.
    Wang J; Hirayasu Y; Hokama H; Tanaka S; Kondo T; Zhang M; Xiao Z
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):209-14. PubMed ID: 15823170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced delta power and synchrony and increased gamma power during the P3 time window in schizophrenia.
    Donkers FC; Englander ZA; Tiesinga PH; Cleary KM; Gu H; Belger A
    Schizophr Res; 2013 Oct; 150(1):266-8. PubMed ID: 23954147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the P300 and P50 waveforms in schizophrenia.
    Bramon E; Rabe-Hesketh S; Sham P; Murray RM; Frangou S
    Schizophr Res; 2004 Oct; 70(2-3):315-29. PubMed ID: 15329307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.
    Turetsky BI; Dress EM; Braff DL; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Light G
    Schizophr Res; 2015 Apr; 163(1-3):53-62. PubMed ID: 25306203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of spectral EEG abnormality as a diagnostic test for schizophrenia.
    Boutros NN; Arfken C; Galderisi S; Warrick J; Pratt G; Iacono W
    Schizophr Res; 2008 Feb; 99(1-3):225-37. PubMed ID: 18160260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia.
    Ozgürdal S; Gudlowski Y; Witthaus H; Kawohl W; Uhl I; Hauser M; Gorynia I; Gallinat J; Heinze M; Heinz A; Juckel G
    Schizophr Res; 2008 Oct; 105(1-3):272-8. PubMed ID: 18625546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    Int J Evid Based Healthc; 2008 Jun; 6(2):137-72. PubMed ID: 21631819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the EEG profiles of early and late responders to antipsychotic treatment in first-episode, drug-naive psychotic patients.
    Merlo MC; Kleinlogel H; Koukkou M
    Schizophr Res; 1998 Apr; 30(3):221-8. PubMed ID: 9589516
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.